Unravelling the regulatory mechanisms of rhythmic insulin secretion: A physiological role for UCP2?
Unravelling the regulatory mechanisms of rhythmic insulin secretion: A physiological role for UCP2?
批准号:
RGPIN-2015-06551
负责人:
Doucette, Christine
金额:
$2.04万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31
中文摘要
24小时的葡萄糖耐量表现出每日的变化,这是由于ç细胞分泌胰岛素的能力出现了强劲和可预测的波动。目前,对24小时周期中节律性胰岛素分泌能力的调节知之甚少。我的研究计划的长期目标是定义调节每日胰岛素分泌波动并最终在24小时内保持葡萄糖稳态的机制路径,特别关注将新陈代谢与胰岛素控制结合在一起的因素。解偶联蛋白2(UCP2)的表达与葡萄糖刺激的胰岛素分泌(GSIS)减少和基础胰岛素分泌(BIS)增加有关。虽然已经出现了一些关于UCP2在?细胞中的功能的假说,但这些研究大多使用应激/疾病状态或超生理条件来评估UCP2在?细胞中的功能。UCP2在健康细胞中的生理相关功能仍有待阐明。这项发现Grant的短期目标是通过研究UCP2在调节每日胰岛素分泌节律中的作用,确定UCP2在健康?细胞中的生理功能,确定UCP2有助于控制每日胰岛素分泌节律的机制,并探索驱动UCP2表达每日节律的生物节律。一般科学方法:我们的总体假设是,奥伯细胞中的UCP2是动态的,是24小时内有节奏的胰岛素分泌和最终血糖稳态的重要调节因子。研究将利用成熟的基于细胞的系统和小鼠模型系统(分别是MIN6细胞和UCP2基因敲除小鼠)来确定胰岛素分泌能力的24小时节律、线粒体生物能量学、基因表达分析、葡萄糖耐量、血浆激素水平和活性氧物种信号谱。UCP2对GSIS和BIS每日周期的机械贡献将使用这些技术进行探索。还将探索生物钟和摄食节律对有节奏的UCP2的影响,以确定UCP2日常节律背后的潜在驱动力。预期的意义:这项研究将使我们能够首次定义UCP2在?细胞中的相关生理功能,同时也为HQP创造良好的训练机会。预计从这项研究中获得的知识将为未来的研究铺平道路,以确定其他新的节律性胰岛素分泌调节因子,并最终拓宽我们对胰岛素分泌调节和葡萄糖稳态的基本机制的理解,更重要的是,使我们能够追求我的研究计划的长期目标。
英文摘要
Glucose tolerance over a 24hr cycle displays daily variations due to robust and predictable fluctuations in the capacity of the ß cell to secrete insulin. Currently, very little is known about the regulation of rhythmic insulin secretory capacity over 24hr cycles. The LONG-TERM OBJECTIVES OF MY RESEARCH PROGRAM are define the mechanistic pathways that regulate daily fluctuations in insulin secretion and ultimately glucose homeostasis over 24hrs, with a particular focus on the factors that couple metabolism to the control of insulin. Uncoupling protein 2 (UCP2) expression in the ß cell is associated with reduced glucose-stimulated insulin secretion (GSIS) and elevated basal insulin secretion (BIS). While some hypotheses have emerged regarding the function of UCP2 in the ß cell, the majority of these studies have used either stressed/diseased states or supra-physiological conditions to assess UCP2 function in the ß cell. A physiologically relevant function for UCP2 in the healthy ß cells remains to be elucidated. The SHORT-TERM OBJECTIVES OF THIS DISCOVERY GRANT are to define a physiological function for UCP2 in healthy ß cells by examining its role in the regulation of daily rhythms of insulin secretion, to define a mechanism by which UCP2 contributes to the control of daily rhythms of insulin secretion, and to explore the biological rhythms that drive daily rhythms of UCP2 expression. GENERAL SCIENTIFIC APPROACH: Our overall HYPOTHESIS is that UCP2 in the ß cell is dynamic and is an important regulator of rhythmic insulin secretion and ultimately glucose homeostasis over 24hrs. Studies utilizing well-established cell-based and mouse model systems (MIN6 cells and a ß cell-specific UCP2 knockout mouse, respectively) will be performed to determine 24hr rhythms of insulin secretion capacities, mitochondrial bioenergetics, gene expression analyses, glucose tolerance, plasma hormone levels and reactive oxygen species signalling profiles. The mechanistic contribution of UCP2 to daily cycles of GSIS and BIS will be explored using these techniques. The impact of the circadian clock and feeding rhythms on rhythmic UCP2 will also be explored to determine the driving force behind daily rhythms of UCP2. EXPECTED SIGNIFICANCE: This study will allow us to define, for the first time, a relevant physiological function for UCP2 in the ß cell, while also creating excellent training opportunities for HQP. It is anticipated that the knowledge gained from this study will pave the way for future studies to define other novel regulators of rhythmic insulin secretion and ultimately broaden our understanding of the fundamental mechanisms of insulin secretion regulation and glucose homeostasis, and importantly, allowing pursuit of the long-term objectives of my research program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unravelling the regulatory mechanisms of rhythmic insulin secretion: A physiological role for UCP2?
-
批准号:RGPIN-2015-06551
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2021
-
负责人:Doucette, Christine
-
依托单位:
Unravelling the regulatory mechanisms of rhythmic insulin secretion: A physiological role for UCP2?
-
批准号:RGPIN-2015-06551
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2020
-
负责人:Doucette, Christine
-
依托单位:
Unravelling the regulatory mechanisms of rhythmic insulin secretion: A physiological role for UCP2?
-
批准号:RGPIN-2015-06551
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2018
-
负责人:Doucette, Christine
-
依托单位:
Unravelling the regulatory mechanisms of rhythmic insulin secretion: A physiological role for UCP2?
-
批准号:RGPIN-2015-06551
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2017
-
负责人:Doucette, Christine
-
依托单位:
Unravelling the regulatory mechanisms of rhythmic insulin secretion: A physiological role for UCP2?
-
批准号:RGPIN-2015-06551
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2016
-
负责人:Doucette, Christine
-
依托单位:
Unravelling the regulatory mechanisms of rhythmic insulin secretion: A physiological role for UCP2?
-
批准号:RGPIN-2015-06551
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2015
-
负责人:Doucette, Christine
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
-
批准号:82371825
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:占贞贞
-
依托单位:
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
-
批准号:32371150
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:井淼
-
依托单位:
NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
-
批准号:82370796
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:蒋怡然
-
依托单位:
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
-
批准号:82371070
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵培泉
-
依托单位:
增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
-
批准号:82371668
-
项目类别:面上项目
-
资助金额:52.00万元
-
批准年份:2023
-
负责人:乔云波
-
依托单位:
蛋白磷酸酶1调节亚基3c(PPP1R3c)调控肝脏糖异生的作用及机制研究
-
批准号:82370810
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陆洁莉
-
依托单位:
慢性乙肝感染中枯否细胞(KC)诱导肝内自然杀伤细胞(NK)向免疫调节功能(regulatory NK)倾斜的机制及在肝纤维化中的作用
-
批准号:81970529
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2019
-
负责人:李海军
-
依托单位:
以PXR、CAR为核心的调控网络、作用机制及其指导环磷酰胺个体化用药的临床转化研究
-
批准号:81173131
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:王雪丁
-
依托单位:
转录因子DNA结合谱绘制新方法及其应用研究
-
批准号:61171030
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:王进科
-
依托单位: